CAR-T cells are an expensive form of cancer treatment, but other techniques may soon supplant them, Elizabeth Tracey reports
July 7, 20251m 5s
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
CAR-T cells, a highly activated immune cell, have been used to treat a solid tumor, stomach cancer, for the first time. Yet the fact remains that CAR-Ts are expensive and time consuming to produce. Johns Hopkins Kimmel Cancer Center director …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/car-t-cells-are-an-expensive-form-of-cancer-treatment-but-other-techniques-may-soon-supplant-them-elizabeth-tracey-reports/"> <span class="screen-reader-text">CAR-T cells are an expensive form of cancer treatment, but other techniques may soon supplant them, Elizabeth Tracey reports</span> Read More »</a></p>